Showing results (561-570 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|August 1, 2014
I walk the line: how to tell MDS from other bone marrow failure conditionsLukasz P Gondek, Amy E DeZernCurrent Hematologic Malignancy Reports|October 25, 2017
Diagnostic and Prognostic Utility of Fluorescence In situ Hybridization (FISH) Analysis in Acute Myeloid LeukemiaPatrick R Gonzales, Fady M MikhailCurrent Hematologic Malignancy Reports|October 25, 2017
Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCNNaveen Pemmaraju, Audun Utengen, Vikas Gupta, et al.Current Hematologic Malignancy Reports|October 25, 2017
Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?Aaron T Gerds, Teresa ChanCurrent Hematologic Malignancy Reports|October 28, 2017
Using Social Media at National Meetings in Hematology-Optimal Use, Tips, Strategies, and LimitationsAaron C LoganCurrent Hematologic Malignancy Reports|October 17, 2017
Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?Brady L Stein, Srdan VerstovsekCurrent Hematologic Malignancy Reports|October 7, 2017
Therapy for Chronic Myelomonocytic Leukemia in a New EraTamara K Moyo, Michael R SavonaCurrent Hematologic Malignancy Reports|October 7, 2017
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jeffrey W Tyner, Jason GotlibCurrent Hematologic Malignancy Reports|August 31, 2017
Minimal Residual Disease Eradication in CML: Does It Really Matter?Srinivas K Tantravahi, Raga S Guthula, Thomas O'Hare, et al.Current Hematologic Malignancy Reports|August 28, 2017
Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDSAziz Nazha, Rafael BejarPageof 86